Pardes Biosciences Inc (PRDS)

Sector:
FINANCE
Industry:
GENERAL FINANCE
CEO:
Thomas G. Wiggans
Employees:
50
2173 SALK AVENUE, SUITE 250, PMB#052, CARLSBAD, CA, 92008
415-649-8758

Pardes Biosciences, Inc. focuses on discovering, developing, and commercializing novel therapeutics. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases.

Data derived from most recent annual or quarterly report
Market Cap 79.637 Million Shares Outstanding61.734 Million Avg 30-day Volume 138.505 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.4
Price to Revenue0.0 Debt to Equity0.0 EBITDA-38.488 Million
Price to Book Value0.2336 Operating Margin0.0 Enterprise Value-206.464 Million
Current Ratio30.704 EPS Growth0 Quick Ratio29.97
1 Yr BETA 0.9072 52-week High/Low 8.75 / 0.75 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score4.6012 Free Cash Flow to Firm 0

Are you looking for this stock instead?

View recent insider trading info

Pardes Biosciences Inc YCharts
Yahoo! Finance finviz

Funds Holding PRDS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PRDS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WIGGANS THOMAS G CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 0 2023-02-01 4

HENSON HEIDI CHIEF FINANCIAL OFFICER

  • Officer
 0 2023-02-01 2

LACY ELIZABETH H. GENERAL COUNSEL, SECRETARY

  • Officer
 0 2023-02-01 2

BRUSKY SEAN P. CHIEF COMMERCIAL OFFICER

  • Officer
 0 2023-02-01 3

KEARNEY BRIAN CHIEF DEVELOPMENT OFFICER

  • Officer
 0 2023-02-01 2

FORESITE CAPITAL MANAGEMENT V, LLC

TANANBAUM JAMES B.

FORESITE CAPITAL FUND V, L.P.

  • Director
  • 10% Owner
 12,809,810 2022-12-01 2

POTTAGE JOHN C JR

  • Director
 75,000 2022-09-14 2

SMALDONE ALSUP LAURIE

  • Director
 0 2022-09-14 2

TINMOUTH BRIAN PHILIPPE CHIEF BUS. & STRATEGY OFFICER

  • Officer
 125,000 2022-09-14 1

LOBELL J JAY

  • Director
 1,363,861 2022-07-19 2

AUERBACH MARK

  • Director
 37,500 2022-06-08 1

TANANBAUM JAMES B.

  • Director
  • 10% Owner
 37,500 2022-06-08 2

VARNEY MICHAEL DAVID

  • Director
 37,500 2022-06-08 1

HAMILL LAURA

  • Director
 37,500 2022-06-08 1

AUTOR DEBORAH M.

  • Director
 37,500 2022-06-08 1

ARNOLD LEE D CHIEF SCIENTIFIC OFFICER

  • Officer
 100,000 2022-02-01 0

LOPATIN URI A PRESIDENT AND CEO

  • Officer
  • Director
 421,000 2022-02-01 0

PAKIANATHAN DEEPIKA

  • Director
 0 2021-12-23 0

HUGHES OWEN

  • Director
 0 2021-12-23 0

TANANBAUM JAMES B.

FORESITE CAPITAL FUND V, L.P.

FORESITE CAPITAL MANAGEMENT V, LLC

FORESITE CAPITAL OPPORTUNITY FUND V, L.P.

FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC

  • Director
  • 10% Owner
 75,000 2021-12-23 2

DUBIN DANIEL

  • Director
 0 2021-12-23 0

FS DEVELOPMENT HOLDINGS II, LLC

  • 10% Owner
 5,476,250 2021-12-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HENSON HEIDI - Officer CHIEF FINANCIAL OFFICER

2023-02-03 16:29:28 -0500 2023-02-01 A 156,250 a 156,250 direct

KEARNEY BRIAN - Officer CHIEF DEVELOPMENT OFFICER

2023-02-03 16:30:38 -0500 2023-02-01 A 156,250 a 156,250 direct

LACY ELIZABETH H. - Officer GENERAL COUNSEL, SECRETARY

2023-02-03 16:34:50 -0500 2023-02-01 A 156,250 a 156,250 direct

WIGGANS THOMAS G - Director - Officer CHIEF EXECUTIVE OFFICER

2023-02-03 16:36:31 -0500 2023-02-01 A 562,500 a 562,500 direct

BRUSKY SEAN P. - Officer CHIEF COMMERCIAL OFFICER

2023-02-03 16:28:20 -0500 2023-02-01 A 156,250 a 156,250 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PARDES BIOSCIENCES INC PRDS 2023-03-24 22:15:03 UTC 1.89 2.93 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 21:45:03 UTC 1.89 2.93 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 21:15:03 UTC 1.89 2.93 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 20:45:03 UTC 1.89 2.93 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 20:15:04 UTC 1.89 2.93 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 19:45:03 UTC 1.89 2.93 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 19:15:04 UTC 1.89 2.93 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 18:45:04 UTC 1.8856 2.9344 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 18:15:03 UTC 1.8856 2.9344 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 17:45:03 UTC 1.8856 2.9344 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 17:15:03 UTC 1.8856 2.9344 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 16:45:03 UTC 1.8354 2.9846 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 16:15:03 UTC 1.8354 2.9846 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 15:45:03 UTC 1.8354 2.9846 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 15:15:03 UTC 1.8354 2.9846 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 14:45:03 UTC 1.8354 2.9846 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 14:15:03 UTC 1.8354 2.9846 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 13:45:03 UTC 1.8583 2.7117 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 13:15:04 UTC 1.8583 2.7117 350000
PARDES BIOSCIENCES INC PRDS 2023-03-24 12:45:03 UTC 1.8583 2.7117 500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund PRDS -1600.0 shares, $-1920.0 2022-10-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund PRDS -3000.0 shares, $-5070.0 2022-12-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund PRDS -1767.0 shares, $-2986.23 2022-12-31 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments